BRENDEN MASDEN: Open Payments
NPI 1144939786 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 11 payments from 8 companies in 2025. Trend: 2023 $30 · 2024 $50 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Lilly USA, LLC | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Corium, LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: JARDIANCE, MOUNJARO, GVOKE HYPOPEN, Wegovy, TRELEGY ELLIPTA, QULIPTA, Azstarys, CONTRAVE.
Industry payments across TX — which companies pay providers there.
